McCarthy Sean A. 4
4 · CytomX Therapeutics, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-03-26−109,768→ 0 totalExercise: $1.57Exp: 2025-02-08→ Common Stock (109,768 underlying) - Exercise/Conversion
Common Stock
2024-03-26$1.57/sh+109,768$172,874→ 634,249 total
Holdings
- 93,158(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Includes 197,500 restricted stock units.
- [F2]Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
- [F3]This option is fully vested and exercisable.
- [F4]The Reporting Person previously transferred 9,768 shares subject to this stock option to a family member.